Wellbiotec Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 0.00001 million. Net loss was KRW 2,294.71 million compared to KRW 3,065.44 million a year ago. Basic loss per share from continuing operations was KRW 26 compared to KRW 1 a year ago. Diluted loss per share from continuing operations was KRW 26. Basic loss per share was KRW 26 compared to KRW 1 a year ago.
For the nine months, sales was KRW 0.00001 million compared to KRW 0.00002 million a year ago. Net loss was KRW 1,106.79 million compared to net income of KRW 537.46 million a year ago. Basic loss per share from continuing operations was KRW 15 compared to basic earnings per share from continuing operations of KRW 8 a year ago. Diluted loss per share from continuing operations was KRW 15 compared to diluted earnings per share from continuing operations of KRW 8 a year ago. Basic loss per share was KRW 15 compared to basic earnings per share of KRW 8 a year ago.